Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

AnteoTech (ASX:ADO): Battery Technology Pivot Expands Materials Science Strategy

AnteoTech Ltd (ASX:ADO) is a specialty chemicals company developing surface chemistry technologies for advanced battery materials and life sciences applications. The company’s strategy has shifted increasingly towards battery technology, where its chemistry is being applied to silicon-anode materials designed for next-generation lithium-ion batteries.

Sonal Goyal | 18 September 2026

Atomo Diagnostics (ASX:AT1): HIV Self-Testing Drives Rapid Diagnostics Growth Strategy

Atomo Diagnostics Limited (ASX:AT1) is an Australian medical device company focused on simplifying rapid diagnostic testing. The company develops integrated testing devices designed to make sample collection and result interpretation easier for users. This article examines how HIV self-testing and platform partnerships are shaping …

Sonal Goyal | 18 September 2026

Invex Therapeutics (ASX:IXC): Strategic Reset Follows Closure of Flagship Brain-Pressure Trial

Invex Therapeutics Ltd (ASX:IXC) is a biotechnology company focused on developing treatments for neurological conditions involving elevated intracranial pressure. The company’s development pathway changed after the closure of its lead clinical trial, placing future strategy andCapitalmanagement at the centre of its current position.

Sonal Goyal | 18 September 2026

EMVision Medical Devices (ASX:EMV): Portable Brain Imaging Technology Targets Stroke Care

EMVision Medical Devices Ltd (ASX:EMV) is an Australian medical technology company developing portable brain imaging systems. The company’s technology aims to support faster assessment of stroke patients by bringing imaging capability closer to the point of care, including hospitals and potentially ambulances. This article …

Sonal Goyal | 18 September 2026

Neurizon Therapeutics (ASX:NUZ): HEALEY ALS Trial Becomes Central Development Milestone

Neurizon Therapeutics Limited (ASX:NUZ) is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative diseases. Its lead programme, NUZ-001, is being investigated as a potential therapy for amyotrophic lateral sclerosis (ALS). This article examines the role of the HEALEY ALS Platform Trial and …

Sonal Goyal | 18 September 2026

Adherium (ASX:ADR): Inhaler Data Platform Targets Digital Respiratory Care Growth

Adherium Limited (ASX:ADR) is a digital respiratory health company focused on improving medication management for people with asthma and chronic obstructive pulmonary disease (COPD). Its Hailie platform combines connected inhaler sensors with digital software tools to support respiratory care monitoring. This article examines the …

Sonal Goyal | 18 September 2026

Cyclopharm (ASX:CYC): Technegas Guidelines Recognition Supports Lung Imaging Expansion

Cyclopharm Limited (ASX:CYC) is an Australian nuclear medicine company focused on developing and commercialising Technegas, a technology that helps clinicians assess lung ventilation during imaging procedures. The company’s recent progress has centred on expanding clinical recognition and supporting broader adoption of its lung imaging …

Sonal Goyal | 18 September 2026

Firebrick Pharma (ASX:FRE): Nasodine Commercial Rollout Becomes the Next Development Phase

Firebrick Pharma Limited (ASX:FRE) is an Australian pharmaceutical company focused on developing and commercialising nasal and throat spray products using povidone-iodine. The company’s NasodineBrandrepresents its move from a development-focusedBusinesstowards a commercial consumer healthcare model, with products being introduced across selected markets.

Sonal Goyal | 18 September 2026

CleanSpace (ASX:CSX): AGILE Respirator Certification Supports Industrial Growth Strategy

CleanSpace Holdings Limited (ASX:CSX) designs and develops powered air-purifying respirators that provide filtered breathing protection across healthcare and industrial environments. The company’s AGILE product represents an expansion of its respiratory protection portfolio, targeting industries where lightweight and comfortable protective equipment is required.

Sonal Goyal | 18 September 2026

Clever Culture Systems (ASX:CC5): Automated Plate Reading Technology Moves Towards Commercial Expansion

Clever Culture Systems Limited (ASX:CC5) is a healthcare technology company focused on laboratory automation solutions. The company develops the Automated Plate Assessment System (APAS) Independence platform, which uses imaging and artificial intelligence to analyse microbiology culture plates. This article examines how the company is …

Sonal Goyal | 18 September 2026
Support

Hi! How can we help you today?

Loading…